Literature DB >> 28348631

Optic Neuropathy As the Initial Presenting Sign of N-methyl-d-aspartate (NMDA) Encephalitis.

Mark Mugavin1, Brett H Mueller1, Masoom Desai2, Karl C Golnik3.   

Abstract

A 52-year-old woman presented with painless vision loss for 3 months. She was in custody for allegedly robbing a bank and had recently been diagnosed with paranoid schizophrenia. She had 20/100 VA OD, a 2+RAPD, and optic atrophy. Extensive diagnostic workup including MRI, Fluorescein Angiography, Infectious Disease Panel, lumbar puncture, and leptomeningeal biopsy were unrevealing. Vision in her right eye declined to NLP and her left eye declined to 20/200 VA. Anti N-methyl-D-aspartate (NMDA) Autoimmune Encephalitis was diagnosed based on CSF serology and clinical suspicion. Her clinical course improved as she was treated with corticosteroids and rituximab.

Entities:  

Keywords:  NMDA encephalitis; optic neuropathy

Year:  2017        PMID: 28348631      PMCID: PMC5354102          DOI: 10.1080/01658107.2016.1262431

Source DB:  PubMed          Journal:  Neuroophthalmology        ISSN: 0165-8107


  9 in total

1.  NMDA receptor encephalitis mimicking seronegative neuromyelitis optica.

Authors:  M C Kruer; T K Koch; D N Bourdette; D Chabas; E Waubant; S Mueller; M A Moscarello; J Dalmau; R L Woltjer; G Adamus
Journal:  Neurology       Date:  2010-05-04       Impact factor: 9.910

2.  Aquaporin-4 antibody neuromyelitis optica following anti-NMDA receptor encephalitis.

Authors:  Marco Zoccarato; Maria Valeria Saddi; Giulia Serra; Maria Federica Pelizza; Irene Rosellini; Luigi Peddone; Anna Ticca; Bruno Giometto; Luigi Zuliani
Journal:  J Neurol       Date:  2013-11-20       Impact factor: 4.849

3.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

Review 4.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

5.  [Anti-NMDA receptor antibody encephalitis with recurrent optic neuritis and epilepsy].

Authors:  Rie Motoyama; Kazuhiro Shiraishi; Keiko Tanaka; Masako Kinoshita; Masami Tanaka
Journal:  Rinsho Shinkeigaku       Date:  2010-08

Review 6.  Anti-NMDAR autoimmune encephalitis.

Authors:  Kazushi Miya; Yukitoshi Takahashi; Hisashi Mori
Journal:  Brain Dev       Date:  2013-11-05       Impact factor: 1.961

7.  A patient with encephalitis associated with NMDA receptor antibodies.

Authors:  Lauren H Sansing; Erdem Tüzün; Melissa W Ko; Jennifer Baccon; David R Lynch; Josep Dalmau
Journal:  Nat Clin Pract Neurol       Date:  2007-05

8.  Sore eyes and psychosis.

Authors:  Samantha Colley; John Smith
Journal:  BMJ Case Rep       Date:  2014-09-05

Review 9.  Antibody-Mediated Autoimmune Encephalopathies and Immunotherapies.

Authors:  Matteo Gastaldi; Anaïs Thouin; Angela Vincent
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

  9 in total
  2 in total

1.  Anti-N-methyl-D-aspartate receptor optic neuritis in a patient without history of encephalopathy.

Authors:  Seyed Mohammad Baghbanian; Abdorreza Naser Moghadasi
Journal:  Taiwan J Ophthalmol       Date:  2019-10-09

2.  Neuro-ophthalmological consequences of acute influenza A encephalitis in a genetically predisposed child.

Authors:  Catarina Xavier; Miguel Boncquet Vieira; Cristina Ferreira; Joana Tavares Ferreira
Journal:  BMJ Case Rep       Date:  2020-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.